Barry Straus, MD
Pain Medicine · Canton, GANPI 1447252861
Payments from drug & device makers
Across 233 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$768
- AbbVie$732
- Boston Scientific$500
- Forte Bio-pharma LLC$469
- Biohaven Pharmaceuticals, Inc.$155
- Pfizer$148
- plus $1K from 21 others
What the payments were for
- Grants$50013%
- Food & beverage$3,39187%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 48 | $768 |
| AbbVie(2 entities) | 81 | $732 |
| Boston Scientific | 1 | $500 |
| Forte Bio-pharma LLC | 24 | $469 |
| Biohaven Pharmaceuticals, Inc. | 8 | $155 |
| Pfizer | 9 | $148 |
| Collegium Pharmaceutical, Inc. | 9 | $141 |
| Supernus Pharmaceuticals, Inc. | 6 | $123 |
| Biodelivery Sciences International, Inc. | 6 | $109 |
| Lilly USA, LLC | 5 | $95 |
| Daiichi Sankyo Inc. | 4 | $70 |
| Amgen | 3 | $63 |
| Vertex | 1 | $61 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $60 |
| Arbor Pharmaceuticals, Inc. | 4 | $58 |
| Sentynl Therapeutics, Inc. | 4 | $57 |
| Impel Pharmaceuticals Inc. | 3 | $49 |
| Hikma Pharmaceuticals USA | 3 | $48 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Kaleo, Inc. | 2 | $33 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| IBSA Pharma Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $14 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
| Protega Pharmaceutials Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,891 in reported general payments places this provider in the 55th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,339 | $421,079 |
| RelistorMethylnaltrexone Bromide | 106 | $264,249 |
| OxycontinOxycodone Hcl | 200 | $248,849 |
| Xtampza ErOxycodone Myristate | 347 | $210,698 |
| Nucynta ErTapentadol Hcl | 52 | $79,482 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,385 | $65,663 |
| PercocetOxycodone Hcl/Acetaminophen | 14 | $64,164 |
| BelbucaBuprenorphine Hcl | 82 | $59,619 |
| Oxycodone Hcl | 2,268 | $54,710 |
| MovantikNaloxegol Oxalate | 105 | $42,993 |
| Fentanyl | 279 | $39,511 |
| UbrelvyUbrogepant | 26 | $38,684 |
| Morphine Sulfate ErMorphine Sulfate | 954 | $31,866 |
| Aimovig AutoinjectorErenumab-Aooe | 36 | $28,052 |
| Hysingla ErHydrocodone Bitartrate | 29 | $24,945 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta Er, Belbuca | $141 | $349,799481 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $768 | $264,249106 claims |
| AbbVieUbrelvy, Linzess, Savella | $732 | $65,68176 claims |
| Redhill Biopharma Inc.Movantik | $18 | $42,993105 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $48 | $20,779147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Canton
- Chitra RamasubbuCanton$6K
- Arnold WeilMarietta$286K
- Jeffrey GrossmanAtlanta$189K
- Vicente GalanStockbridge$95K
- Rutvij ShahColumbus$86K
- Anthony GrassoMarietta$79K
- Subodh AgrawalAthens$76K
- Maged HamzaGainesville$50K
- Siddardth UmapathyFort Eisenhower$41K
- Susheel DuaAtlanta$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.